InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel
June 02, 2022 08:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, June 02, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) ("InterCure" or the “Company”) announced today the grand opening...
InterCure Begins 2022 with Record Breaking First Quarter Financial Results
May 16, 2022 17:50 ET
|
InterCure Ltd.
Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to $8 million Net income of $6 million for the Q1 of 2022 compared to $2...
InterCure to Release its Q1 2022 Results and Hold a Conference Call
May 16, 2022 01:30 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, May 16, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...
InterCure to Participate in Upcoming Investor Conferences in May 2022
May 09, 2022 11:20 ET
|
InterCure Ltd.
NEW YORK, TORONTO, and HERZLIYA, Israel, May 09, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure" or the “Company”) today announced that...
InterCure to Participate in A.G.P.’s Spring Consumer Cannabis Conference
May 03, 2022 11:28 ET
|
InterCure Ltd.
NEW YORK and TORONTO and HERZLIYA, Israel, May 03, 2022 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc) ("InterCure" or the “Company”) today announced that...
InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results
April 06, 2022 00:39 ET
|
InterCure Ltd.
Another record year with continued industry leading growth and profitability supported by focused strategy and execution Revenue growth expected to continue in the first quarter and throughout 2022 ...
InterCure Expects to Publish its full Audited Fourth Quarter and Full Year 2021 Results Prior to the TSX Closing on April 5, 2022
April 05, 2022 08:47 ET
|
InterCure Ltd.
Delay in publication of the Audited Results due to immaterial technical audit matters The Company expects the Audited Results will not differ from announced preliminary results NEW YORK and TORONTO...
CORRECTING and REPLACING -- InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
April 04, 2022 09:33 ET
|
InterCure Ltd.
Fourth quarter 2021 Revenue and Adjusted EBITDA2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted...
InterCure Estimates Record Fourth Quarter and Fiscal Year End 2021 Results(1)
April 04, 2022 08:29 ET
|
InterCure Ltd.
Fourth quarter 2021 Revenue and Adjusted EBITDA2 of $33 million and $9 million, representing an increase of almost 200% and 140% YoY, respectively Record fiscal year 2021 revenue and Adjusted...
InterCure to Announce Q4 & Year-End 2021 Financial Results on April 4, 2022
April 03, 2022 03:35 ET
|
InterCure Ltd.
Will release financial results for the fourth quarter of 2021 before market open on Monday, April 4, 2022 Webcast scheduled for same day at 8:30am ET NEW YORK, TORONTO, and HERZLIYA, Israel, April ...